NICE: ‘lot of work’ to do on VBP
November 30, 2012Medical Communications, Sales and Marketing Boysen, NHS, NICE, QALY, VBP
NICE is still working out what its role with the new NHS Commissioning Board will be, with other key issues …
Novartis R&D warning
November 29, 2012Research and Development, Sales and Marketing NHS, Novartis. R&D, trials
Novartis has hit out at what it sees as the high cost of UK clinical trials, warning that business will …
Eylea approval for wet AMD
November 29, 2012Sales and Marketing Bayer, Eylea, Lucentis, Novartis, avastin, wet AMD
Bayer HealthCare’s Eylea has been appoved in Europe for the treatment of neovascular age-related macular degeneration (wet AMD). The eye …
Genzyme appoints new GM for UK and Ireland
November 29, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brendan Martin, Genzyme
Genzyme has announced the appointment of Brendan Martin as general manager for UK and Ireland. Martin will be responsible for …
Survey: pharma losing $564 billion each year
November 28, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cap Gemini, Health Prize, pharma
Pharma companies are losing $564 billion each year – more than half the industry’s $956 billion revenue worldwide last year …
Another indication for Humira
November 28, 2012Sales and Marketing Abbott, Crohn's, EU, Humira
Abbott’s Humira has received its ninth indication in Europe with approval to treat youngsters suffering from the inflammatory bowel disease …
RSA welcomes new starter
November 28, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huberts, rsa
Life Sciences Executive Search and Interim Management specialists RSA, has announced that Michael Huberts has joined the UK business as …
TranslateMedia listed in the Deloitte UK Fast 50 for the third year running
November 27, 2012Medical Communications
International translation and transcreation agency, TranslateMedia has been listed in the Deloitte UK Fast 50 for the third consecutive year, …
EMA’s five points on data release
November 27, 2012Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Rasi, transparency
The European Medicines Agency has highlighted five areas that need to be ironed out before it begins publishing clinical trial …
‘Adopt NICE decisions’ committee told
November 27, 2012Sales and Marketing ABPI, Dorrell, NHS, NICE, Whitehead
ABPI chief executive Stephen Whitehead has again urged the NHS to adopt and use the drugs which NICE approves, and …
Targacept confirms Stephen Hill as president and chief executive
November 27, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targacept, stephen hill
Clinical-stage biopharma firm Targacept has announced that Stephen Hill has been appointed as president and chief executive. Hill is expected …
Glass particles force recall of Ranbaxy Lipitor
November 27, 2012Manufacturing and Production, Sales and Marketing Daiichi Sankyo, Lipitor, Pfizer, Ranbaxy, recall
Ranbaxy Pharmaceuticals is recalling around 40 batches of its generic atorvastatin tablets after discovering that some of the product may …
UCB sells Indian production plant to Exemed
November 27, 2012Manufacturing and Production API, Exemed, UCB, vapi
UCB Pharma has signed a deal to sell its manufacturing facility in Vapi, India, to local firm Exemed Pharmaceuticals. The …
MPs pharma investigation in offing
November 26, 2012Sales and Marketing ABPI, Bad pharma, M&P, MP, NICE, trial data
A health select committee inquiry into pharma companies withholding clinical trial data is being considered, according to committee chair Stephen …
Summit appoints two non-executive directors
November 26, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Frank Armstrong, Jim Mellon, summit
UK drug discovery and development firm Summit has appointed Jim Mellon and Dr Frank Armstrong as non-executive directors. The additions …
Vifor ad breaches Code
November 26, 2012Sales and Marketing ABPI, PMCPA, Vifor, ferinject
Vifor has been blasted after failing to adhere to an earlier ruling made under the ABPI’s Code of Practice. Such …
Roche to release Tamiflu data
November 23, 2012Sales and Marketing BMJ, Cochrane, Goldacre, NHS, Roche, Tamiflu
Roche has said it will let researchers have access to more data on its influenza vaccine Tamiflu, apparently under pressure …
Burson-Marsteller appoints Kate Hawker as MD and chair
November 23, 2012Medical Communications, Sales and Marketing Burson-Marsteller
PR firm Burson-Marsteller has hired pharma comms expert Kate Hawker as managing director and chair of both its EMEA and …
NICE medicines uptake dissected
November 23, 2012Sales and Marketing HSCIC, IMS, NICE
Lack of diagnosis, ignoring required tests, muddled commissioning and local policy variations are among the key reasons why NICE-approved drugs …
GSK’s Promacta extends US licence
November 22, 2012Sales and Marketing FDA, GSK, Promacta, Revolade
GlaxoSmithKline’s Promacta has received a new indication from the FDA which means it can be used for patients with thrombocytopenia …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
